FDA Orange Book · active-ingredient family
Capsaicin
Capsaicin is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:QUTENZA · NDA 022395
1
Brand (NDA)
0
Generics (ANDA)
2
Listed patents
0
Exclusivity periods
Brand (NDA) products · patch
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| QUTENZARLD | AVERITAS | NDA 022395 | — | Nov 16, 2009 |
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9226903 | Dec 15, 2028 | in 2 yr 6 mo | Product |
| 8821920 | Mar 26, 2030 | in 3 yr 10 mo | Product |
Capsaicin — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
